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Key Findings  
 
 The cholesterol level of the 
population reached its 
highest peak in the 1970s. 
 The level declined until 
2007 by as much as 20%, 
but then started to increase 
again by 2–3 percent. 
 The main reason for the 
decline of serum cholester-
ol levels is the diet becom-
ing healthier.  
 The slight increase in the 
serum cholesterol levels in 
the last few years is caused 
by the increased intake of 
saturated fats. 
 The incidence of coronary 
heart disease can be re-
duced further by lowering 
the serum cholesterol level. 
 
INTRODUCTION 
The World Health Organization (WHO) has published its action plan for the prevention and 
control of noncommunicable diseases for 2013−2020. The action plan includes proposals 
for health policy and practical action. The objective is for the member states to reach as 
many as possible of the nine international targets pertaining to the prevention and treat-
ment of noncommunicable diseases by the year 2025. The attainment of the said targets 
is being monitored through 25 indicators, which represent risk of premature mortality, 
levels of noncommunicable disease risk and protective factors as well as the potential for 
and realisation of prevention and treatment. The baseline of the monitoring is year 2010. 
The WHO action plan is primarily focused on four important disease groups: cardiovascu-
lar diseases, cancer, diabetes and chronic respiratory diseases. Disease prevention focuses 
on lifestyle factors: smoking, unhealthy diet, lack of physical activity, and harmful use of 
alcohol. 
An evaluation has been conducted in Finland on the current state and previous develop-
ment of noncommunicable diseases and their risk factors to estimate how realistic the 
targets set by WHO are for Finland. At the same time, national challenges have been iden-
tified along with possibilities for improving the prevention of noncommunicable diseases. 
This “Data Brief” publication reports WHO’s indicators 15, 17 and 18, pertaining to the 
population’s serum cholesterol level, intake of saturated fat and implementation of 
dyslipidemia drug treatment.  
TRENDS IN SERUM CHOLESTEROL IN FINLAND  
The average serum cholesterol level of the Finnish population in the early 1970s was rec-
ord high, almost 7 mmol/L. After that, the level had dropped by approximately 20% by 
2007.  According to the FINRISK survey of 1982, approximately 80% of the population had 
a cholesterol level higher than the recommended 5 mmol/L. By 2007, the percentage of 
the population exceeding the recommended level had dropped to roughly 56%, but by 
2012 the number had once again climbed to approximately 60% (Figure 1).  Similar chang-
es were also evident in the average cholesterol level of the population: a steep decline 
between 1982 and 2007 and then a 2–3 percent rise between 2007 and 2012 (Figure 2).  
Figure 1. 
The percentage (%) of men and women with a high serum choles-
terol level (≥5 mmol/L), age group 25–64. 
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Figure 2. 
Average serum cholesterol levels (mmol/L) among men and  
women of 25 to 64 years of age. 
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The main reason for the decline of serum cholesterol levels is the diet becoming health-
ier. The proportion of saturated fats from total energy intake dropped from approxi-
mately 20% in 1982 to 12% in 2007, with the proportion of polyunsaturated fats in-
creasing (Figures 3 & 4). The main factor here has been a decrease in the use of milk 
fat, which has been substituted by liquid vegetable oils.  A decrease in the amount of 
cholesterol and trans fats consumed with food has also had some impact. The slight 
increase in the cholesterol levels between 2007 and 2012 was purely down to a change 
in fat type. Milk fat-based foods became more popular at the expense of vegetable oil-
based foods. 
 
Figure 3. 
The daily intake of fat and fatty acids among men of 25–64 years 
of age as a percentage of total energy intake.  
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WHO indicators for cholesterol, 
the intake of saturated fats, and 
lipid-lowering drugs 
 
Age-standardized mean proportion of 
total energy intake from saturated fatty 
acids in persons aged 18+ years  
 
Age-standardized prevalence of raised 
total cholesterol among persons aged 
18+ years (defined as total cholesterol 
≥5.0 mmol/l or 190 mg/dl); and mean 
total cholesterol concentration 
 
Proportion of eligible persons (defined as 
aged 40 years and older with a 10-year 
cardiovascular risk ≥30%, including those 
with existing cardiovascular disease) 
receiving drug therapy and counselling 
(including glycaemic control) to prevent 
heart attacks and strokes 
 
1. It should be noted that these 
indicators cannot be created from 
the Finnish information sources 
exactly in the same form.  
WHO targets for 2010–2025 
 
1. A 25% relative reduction in risk 
of premature mortality from 
cardiovascular diseases, cancer, 
diabetes and chronic respiratory 
diseases. 
2. At least 10% relative reduction in 
the harmful use of alcohol, as 
appropriate, within the national 
context. 
3. A 10% relative reduction in 
prevalence of insufficient physi-
cal activity. 
4. A 30% relative reduction in 
mean population intake of 
salt/sodium. 
5. A 30% relative reduction in 
prevalence of current tobacco 
use in persons aged 15+ years. 
6. A 25% relative reduction in the 
prevalence of raised blood pres-
sure. 
7. Halt the rise in diabetes and 
obesity. 
8. At least 50% of eligible people 
receive drug therapy and coun-
selling to prevent heart attacks 
and strokes 
9. An 80% availability of the afford-
able basic technologies and es-
sential medicines required to 
treat major noncommunicable 
diseases.  
Men 
Women 
 
    Vartiainen, Laatikainen, Jousilahti, Tapanainen  The goal of WHO to lower the mortality rate is achievable – but 
the requisite is to lower the level of cholesterol 
 
 
National Institute for Health and Welfare (THL) – 
Data Brief 26/2015 
           3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The materials used 
 
THL conducts the National FINRISK 
Study every five years. The purpose 
of this set of surveys is to monitor 
the risk factor levels of cardiovascu-
lar diseases as well as other non-
communicable diseases, and the 
changes therein in Finland. 
 
Dietary information is based on the 
FINDIET survey implemented as a 
sub-sample of the FINRISK survey.  
 
Figure 4. 
The daily intake of fat and fatty acids among women of 25 to 64 
years of age as a percentage of the total energy intake.  
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Cholesterol lowering medication has also played a small role in the reduction of the 
population’s serum cholesterol level.  The start of the use of statins in the late 1980s 
has lowered the average cholesterol level by 0.14 mmol/L for men and 0.06 mmol/L 
for women between 1982 and 2012.   
In 2012, cholesterol lowering medication was used by 21% of men and 15% of women 
in the 35-74 age group. Cholesterol lowering medication was used by 80% of myocar-
dial infarction patients, 85% of bypass patients, and 90% of PTCA patients. Ergo, medi-
cation is at a good level among heart disease patients. Nevertheless, there is still room 
for improvement when it comes to cholesterol lowering medication. In 2012, based on 
the FINRISK calculator, a third of the men aged 35–74 had at least a 10% risk of getting 
coronary heart disease within the next ten years. The total cholesterol level was below 
5 mmol/L for less than a third of them. Respectively, for 7% of women the risk was 
higher than 10%. The total cholesterol level was below 5 mmol/L for 18% of them.  
This high-risk group would benefit from medication.   
Since 1972, lower serum cholesterol levels have been the single most important factor 
in the decline in deaths caused by heart disease. This alone explains almost half of the 
decline in the mortality rate.  If the intake of saturated fats could be lowered from the 
current 14% to the recommended 10% or less, and the intake could be substituted by 
polyunsaturated fats, the cholesterol level in blood would drop by 6%. This would 
bring down the average cholesterol level of the population to approximately 5 mmol/L. 
This, in turn, would reduce coronary heart disease by 12–18 percent. There are ap-
proximately 22,000 new CHD cases every year in Finland, so these measures would 
prevent 2,600–3,900 CHD cases per year.   
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SUMMARY 
Significant dietary changes have taken place in Finland in the last decades. This has 
resulted in a decline of approximately 20% in the population’s serum cholesterol level. 
Lower cholesterol level has been a key factor in reducing CHD in Finland. For the ma-
jority of the population, however, the cholesterol level is higher than the recom-
mended 5 mmol/L. The recommended dietary changes would result in considerable 
health benefits. Even so, it appears that the intake of saturated fats contrary to the 
recommendations has increased in the last years, with the cholesterol levels simulta-
neously rising. By targeting the cholesterol lowering medication on the high-risk 
groups, the risk of getting CHD or dying could be reduced further. 
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